Provided by Tiger Trade Technology Pte. Ltd.

BOAN BIOTECH

2.835
+0.0200.71%
Volume:5.85M
Turnover:16.17M
Market Cap:1.74B
PE:195.56
High:2.845
Open:2.825
Low:2.665
Close:2.815
52wk High:15.960
52wk Low:2.665
Shares:615.00M
HK Float Shares:615.00M
Volume Ratio:1.02
T/O Rate:0.95%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.014
ROE:-4.11%
ROA:-1.28%
PB:0.56
PE(LYR):195.56
PS:2.39

Loading ...

Shandong Boan Bio proposes H-share restricted share unit incentive scheme

Reuters
·
Apr 28

BOAN BIOTECH Secures CDE Approval to Launch Phase II Trial of BA1106 + BA1104 for Driver-Gene-Negative NSCLC

Bulletin Express
·
Apr 26

BOAN BIOTECH Receives CDE Acceptance for Phase II Trial Application of BA1106 Combined with BA1104 in Non-Small Cell Lung Cancer

Stock News
·
Apr 26

Shandong Boan says China CDE accepts Phase II trial application for BA1106-BA1104 combo in NSCLC

Reuters
·
Apr 26

Boan Biotech’s March Filing Shows Stable Share Base and Sufficient Public Float

Bulletin Express
·
Apr 08

BRIEF-Shandong Boan Biotechnology Says Dou Changlin Resigned As Executive Director

Reuters
·
Apr 01

BOAN BIOTECH Announces Executive Reshuffle and Strategic Committee Changes

Stock News
·
Mar 31

Boan Biotech Announces Retirement of Executive Director Dr. Dou and Strategy Committee Realignment Effective 31 March 2026

Bulletin Express
·
Mar 31

Shandong Boan Biotechnology - Dou Changlin Resigned as Executive Director

THOMSON REUTERS
·
Mar 31

Stock Track | BOAN BIOTECH Plummets 5.15% Intraday After Reporting 90.24% Profit Drop in FY2025 Results

Stock Track
·
Mar 31

BOAN BIOTECH Reports Annual Results: Profit Attributable to Owners Narrows Significantly

Stock News
·
Mar 31

Boan Biotech FY25 profit drops 90.24% to RMB 7.1 million; revenue rises 8.1% to RMB 780 million

Reuters
·
Mar 30

Shandong Boan Biotechnology FY Revenue RMB 784.8 Million

THOMSON REUTERS
·
Mar 30

BOAN BIOTECH (06955) Sets 30 March 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend

Bulletin Express
·
Mar 17